|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
N/A
|
National Institutes of Health
|
|
Linxian nutrition intervention trial follow-up study
|
ZIA CP000112 00377
|
$41,189
|
Abnet, Christian
|
DCEG (NCI)
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112 10339
|
$128,054
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185 10361
|
$65,336
|
Abnet, Christian
|
DCEG (NCI)
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
ATBC Study
|
ZIA CP010195 03031
|
$738,165
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
BB Biorepository Archive
|
ZIA CP010192 10330
|
$24,304
|
Albert, Paul
|
DCEG (NCI)
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
|
5R01CA183101-04
|
$620,486
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
The Role of RHOA in Diffuse Gastric Cancer
|
1R01CA224428-01
|
$677,302
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Radiobiology Outreach
|
ZIA CP010222 10441
|
$66,403
|
Berrington, Amy
|
DCEG (NCI)
|
|
Breaking the paradigm: RhoA as a tumor suppressor in cancer
|
5F31CA216965-02
|
$30,558
|
BLAKE, DEVON
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-05S1
|
$670,913
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-05
|
$8,625,592
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$396,445
|
Bottaro, Donald
|
CCR (NCI)
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-05
|
$898,424
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Genome-wide Association Study (GWAS) of Gastric Cancer in Hispanic/Latino Populat
|
ZIA CP005803 10823
|
$35,774
|
Camargo, Constanza
|
DCEG (NCI)
|
|
Gastric Cancer Precursor Lesions (GCPL) study
|
ZIA CP010182 10793
|
$434,548
|
Camargo, Constanza
|
DCEG (NCI)
|
|
NCTN Lead Academic Participating Sites Application
|
5U10CA180838-05
|
$623,046
|
CAREY, LISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Therapeutic potential of antitumorigenic soluble MET variants induced by splicing interference
|
1R01CA219689-01A1
|
$372,340
|
CARTEGNI, LUCA
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
Genetic studies of homologous recombination deficiency in hispanic gastric cancer
|
1R01CA223978-01
|
$617,977
|
CARVAJAL CARMONA, LUIS
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target
|
3R01CA204345-03S1
|
$102,584
|
CASERO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target
|
5R01CA204345-03
|
$630,557
|
CASERO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
|
5R01CA204113-03
|
$759,503
|
CHEN, YU
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cellular In vivo Imaging
|
ZIA BC 010657
|
$818,272
|
Choyke, Peter
|
CCR (NCI)
|
|
Barrett's Esophagus Consortium
|
ZIA CP010220 10593
|
$17,435
|
Cook, Michael
|
DCEG (NCI)
|
|
NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network
|
5U10CA180863-05
|
$2,407,344
|
DANCEY, JANET
|
QUEEN'S UNIVERSITY AT KINGSTON
|
|
Early Detection of Esophageal Cancer
|
ZIA CP000185 10317
|
$54,745
|
Dawsey, Sandy
|
DCEG (NCI)
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-05
|
$357,057
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
The Role of Aurora Kinase in Upper Gastrointestinal Adenocarcinomas
|
5R01CA131225-12
|
$345,375
|
EL-RIFAI, WAEL
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Cancer Health Disparities Training Program
|
5T32CA128582-10
|
$175,581
|
ENG, EUGENIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Detection of metastases in lymph nodes using quantitative ultrasound
|
5R01CA192407-04
|
$627,097
|
FELEPPA, ERNEST
|
RIVERSIDE RESEARCH INSTITUTE
|
|
Gastric cancer: Randomized multi-intervention trial to inhibit precancerous ga
|
ZIA CP010182 00446
|
$25,463
|
Gail, Mitchell
|
DCEG (NCI)
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.
|
1R01CA228512-01
|
$504,230
|
GIANNAKAKOU, PARASKEVI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Esophageal cancer genetic studies
|
ZIA CP010224 08138
|
$156,202
|
Goldstein, Alisa
|
DCEG (NCI)
|
|
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
|
5R01CA206188-04
|
$1
|
HOTOPP, JULIE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)
|
5P20CA217231-02
|
$247,999
|
IRAZOLA, VILMA
|
INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|